chr10-103602055-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394015.1(SH3PXD2A):c.3163G>T(p.Val1055Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1055M) has been classified as Uncertain significance.
Frequency
Consequence
NM_001394015.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SH3PXD2A | NM_001394015.1 | c.3163G>T | p.Val1055Leu | missense_variant | 15/15 | ENST00000369774.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SH3PXD2A | ENST00000369774.9 | c.3163G>T | p.Val1055Leu | missense_variant | 15/15 | 5 | NM_001394015.1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.00000408 AC: 1AN: 245398Hom.: 0 AF XY: 0.00000756 AC XY: 1AN XY: 132272
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1455288Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 723166
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 29 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.3079G>T (p.V1027L) alteration is located in exon 14 (coding exon 14) of the SH3PXD2A gene. This alteration results from a G to T substitution at nucleotide position 3079, causing the valine (V) at amino acid position 1027 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at